aTyr Pharma Announces Second Quarter 2021 Results and Provides Corporate Update
Data from Phase 1b/2a clinical trial of ATYR1923 in pulmonary sarcoidosis expected in mid-September 2021….
Month: August 2021
Letter to Shareholders from the Chairman of the Board Ilya Shpurov
Nicosia, Cyprus, Aug. 10, 2021 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC: (RAFA) shares the…
Cosmos Holdings to Open Flagship Store on Alibaba’s Tmall Global, World’s Largest Cross-Border E-Commerce Marketplace with 500M Monthly Active Users
Company Partners with Leading China E-Commerce Solutions Provider REMAI to Launch Sky Premium Life Products…
INmune Bio, Inc. to Present at the Canaccord Genuity 41st Annual Growth Conference
BOCA RATON, Florida, Aug. 10, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”),…
Medexus Schedules First Quarter Fiscal 2022 Conference Call
TORONTO and CHICAGO, Aug. 10, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or…
Longeveron to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 13, 2021
MIAMI, Aug. 10, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Skye Bioscience Completes THCVHS IND-enabling In Vitro Genotoxicity Studies
THCVHS shows no signs of chromosomal or gene mutations in preclinical studies SAN DIEGO, CA,…
Mindset Pharma Announces Preclinical Results Demonstrating Superior Efficacy, Safety and Shorter Duration of Action Across Multiple Next Generation Psychedelic Drug Families
Mindset has identified several potential leads across its psilocybin/psilocin and DMT/5-MeO-DMT analogs that demonstrate superior…
Vallon Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Update
– Company continues to drive enrollment in pivotal intranasal abuse study evaluating ADAIR toward completion…
Harmony Biosciences Reports Second Quarter 2021 Financial Results and Business Updates
WAKIX® (pitolisant) Net Revenue of $73.8 Million for Second Quarter 2021 vs. $38 Million for…
Rain Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Progress
First patient dosed in Phase 3 registrational trial (MANTRA) evaluating milademetan (RAIN-32) in patients with…
Tautachrome: (OTC: TTCM) Matt Moneymaker of the TV Show “Finding Bigfoot” on Animal Planet, partners with Tautachrome to Utilize Tautachrome’s ARknet Platform to Grow Citizen-Science Communities
ORO VALLEY, Ariz., Aug. 10, 2021 (GLOBE NEWSWIRE) — Tautachrome (OTC: TTCM), the developer of…
Wolters Kluwer’s Enablon Established as a Leader in Newly-Launched Process Safety Management Green Quadrant
Market-leading approach interconnects Environment, Health, Safety (EHS) & Sustainability with Operational Risk Management (ORM) Software…
LaunchDarkly Raises $200 Million in Series D Financing, Tripling Valuation to $3 Billion
Leading Feature Management & Experimentation platform accelerates software testing and deployment to increase quality, pace…
Influ2 Accelerates Revenue Growth and Builds Trust with Customer Wins, New Capability and Increased Security
Influ2 moves forward with year-on-year triple-digit revenue and customer growth, a New Audience Discovery Capability,…
Sentieo Hosts Inaugural Customer Advisory Board Meeting for Investment Managers
Customers including Ardevora, Berenberg, and Magellan discuss value of fully integrated platform to support modern…
SADA and Intel® Launch Cloud Optimization Program
The two companies have partnered to offer Google Cloud customers the latest Intel technologies to…
DecisionLink Honors First Cohort to Earn Value Black Belt Certification
Ten initial black belt graduates have attained the highest level of value leadership certification, demonstrating…
Get the NordPass password manager with 70% off
LONDON, Aug. 10, 2021 (GLOBE NEWSWIRE) — With the back-to-school season in full swing, the…
Vineti announces agreement with Imvax to utilize Vineti’s PTM Essentials™ solution
Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s…